AU2690995A - Non-hiv antibodies as disease markers - Google Patents

Non-hiv antibodies as disease markers

Info

Publication number
AU2690995A
AU2690995A AU26909/95A AU2690995A AU2690995A AU 2690995 A AU2690995 A AU 2690995A AU 26909/95 A AU26909/95 A AU 26909/95A AU 2690995 A AU2690995 A AU 2690995A AU 2690995 A AU2690995 A AU 2690995A
Authority
AU
Australia
Prior art keywords
disease markers
hiv antibodies
hiv
antibodies
markers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26909/95A
Inventor
Howard B. Urnovitz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Calypte Inc
Original Assignee
Calypte Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calypte Inc filed Critical Calypte Inc
Publication of AU2690995A publication Critical patent/AU2690995A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • AIDS & HIV (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU26909/95A 1994-05-23 1995-05-23 Non-hiv antibodies as disease markers Abandoned AU2690995A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US321689 1989-03-10
US24820094A 1994-05-23 1994-05-23
US248200 1994-05-23
US32168994A 1994-10-12 1994-10-12
PCT/US1995/006549 WO1995032311A1 (en) 1994-05-23 1995-05-23 Non-hiv antibodies as disease markers

Publications (1)

Publication Number Publication Date
AU2690995A true AU2690995A (en) 1995-12-18

Family

ID=26939190

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26909/95A Abandoned AU2690995A (en) 1994-05-23 1995-05-23 Non-hiv antibodies as disease markers

Country Status (4)

Country Link
EP (1) EP0763137A1 (en)
AU (1) AU2690995A (en)
CA (1) CA2191099A1 (en)
WO (1) WO1995032311A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6344550B1 (en) 1996-01-11 2002-02-05 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
KR19990077146A (en) * 1996-01-11 1999-10-25 길리스 스티브 Compositions and methods for treating and diagnosing breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6586570B1 (en) 1996-01-11 2003-07-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6861506B1 (en) 1996-01-11 2005-03-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6423496B1 (en) 1996-01-11 2002-07-23 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6225054B1 (en) 1996-01-11 2001-05-01 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
ZA982968B (en) * 1997-04-09 1998-10-27 Corixa Corp Compositions and methods for the treatment and diagnosis of breast cancer
WO2009046860A2 (en) * 2007-09-11 2009-04-16 Mondobiotech Laboratories Ag Use of dago as a therapeutic agent
WO2009033818A2 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of a peptide as a therapeutic agent

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4822606A (en) * 1986-04-07 1989-04-18 Duke University Immunosuppressive synthetic peptides and analogs thereof based on retroviral envelope sequences
US5320940A (en) * 1989-05-19 1994-06-14 Board Of Regents, The University Of Texas System Methods and compositions for identifying and characterizing individuals having autoimmune rheumatic diseases
EP1314429A3 (en) * 1990-05-21 2003-06-04 The Administrators Of The Tulane Educational Fund Use of an antiretroviral compound to manufacture a medicament for the treatment of sjogren's syndrome, systematic lupus erythematosis, scleroderma, or juvenile rheumatoid arthritis

Also Published As

Publication number Publication date
CA2191099A1 (en) 1995-11-30
EP0763137A1 (en) 1997-03-19
WO1995032311A1 (en) 1995-11-30

Similar Documents

Publication Publication Date Title
AU3811495A (en) Antibodies
AU2958997A (en) Concentrated antibody preparation
AU5267190A (en) Modified antibodies
AU1290001A (en) Antibodies
GB9603256D0 (en) Antibodies
AU1462300A (en) Human pan-hcv human monoclonal antibodies
AU4935000A (en) Antibodies
AUPM411994A0 (en) Epitopes
AU1963595A (en) Urine collection means
AUPN178995A0 (en) Antigen composition
AU2690995A (en) Non-hiv antibodies as disease markers
AUPP038697A0 (en) Improved stomach-action molluscicides
AU5970198A (en) Anti-fas antibodies
AU4602093A (en) Folding cat trap
AU3308495A (en) New Toxoplasma gondii antigens
AU2750397A (en) Antibodies directed against dithiocarbamates
AU7862291A (en) Modified antibodies
GB9726147D0 (en) Antigens
AUPM447694A0 (en) Antigen composition
AUPM430294A0 (en) Polymer antibody attachment
GB9401597D0 (en) Altered antibodies
GB9406244D0 (en) Altered antibodies
AUPO589497A0 (en) Novel helicobacter antigens
GB9415331D0 (en) Antibodies
GB9406243D0 (en) Antibodies